We are live on ! Find out more
TROVU

TrovaGene, Inc. - Unit
TROVU

Delisted

TROVU was delisted on the 26th of May, 2017.

Back to rankings

2 hedge funds and large institutions have $2K invested in TrovaGene, Inc. - Unit in 2017 Q1 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
+2
Holders Change %
–
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$1.02K
2
UBS Group
UBS Group
Switzerland
+$1K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1K +$1K +240 New
TRCT
2
Tower Research Capital (TRC)
New York
$1K +$1.02K +245 New

TROVU Hedge Fund Activity: Q1 2017 in Review

2 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. - Unit (TROVU) for Q1 2017, worth a combined $2K.

Buyers outnumbered sellers: 2 funds opened new TROVU positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $1.02K.

  • 2 institutional investors held TrovaGene, Inc. - Unit (TROVU) as of Q1 2017, up from 0 in Q4 2016.
  • Funds reported $2K of TrovaGene, Inc. - Unit stock for Q1 2017.
  • 2 funds opened new TrovaGene, Inc. - Unit positions in Q1 2017 and 0 closed out, a net change of +2 holders.
  • The largest TrovaGene, Inc. - Unit buyer in Q1 2017 was Tower Research Capital (TRC), an estimated $1.02K added.

Based on aggregated 13F filings for Q1 2017.